01 Dr. Reddy's Laboratories (3)
02 Sanofi (3)
03 Pharmathen SA (3)
04 2care4 (1)
05 Amdipharm Mercury Debtco Limited (12)
06 Biological E (3)
07 Cross Pharma AB (3)
08 Farm Agon (2)
09 Future Health Pharma GmbH (3)
10 Institut Produits Synthèse (IPSEN) AB (3)
11 Institute Produits Synthèse (3)
12 InvaGen Pharmaceuticals Inc (3)
13 Ipsen (22)
14 Medartuum AB (6)
15 ORIFARM GROUP AS (15)
16 Omnia Pharmaceutical AB (1)
17 Pharmachim AB (3)
01 Injection (6)
02 Injection fluid, resolution in the finished filled syringe (9)
03 Lanreotide 120Mg 1 Unit Parenteral Use (1)
04 Lanreotide 30Mg 1 Unit Parenteral Use Rp (1)
05 Lanreotide 60Mg 1 Unit Parenteral Use (1)
06 Lanreotide 90Mg 1 Unit Parenteral Use (1)
07 Long Acting Injectable (3)
08 PFS (3)
09 Pre Filled Syringe (3)
10 SOLUTION (EXTENDED RELEASE) (3)
11 SOLUTION FOR INJECTION, PRE-FILLED SYRINGE (28)
12 SOLUTION;SUBCUTANEOUS (6)
13 Blank (24)
01 EU Approved (3)
02 Lead Market Dossiers- Under Development (3)
03 Originator (3)
04 Prescription (3)
05 RX (6)
06 Blank (71)
01 Ipstyl (9)
02 Ipstyl AUTOGEL (6)
03 Ipstyl Autogel (4)
04 LANREOTIDE ACETATE (3)
05 Mytolac (12)
06 SOMATULINE AUTOGEL (3)
07 SOMATULINE AUTOGEL 120 (1)
08 SOMATULINE AUTOGEL 60 (1)
09 SOMATULINE AUTOGEL 90 (1)
10 SOMATULINE DEPOT (3)
11 Somatulina AUTOGEL (6)
12 Somatuline AUTOGEL (16)
13 Somatuline Autogel (12)
14 Blank (12)
01 Australia (24)
02 Canada (3)
03 Greece (3)
04 India (6)
05 Italy (4)
06 Norway (9)
07 South Africa (3)
08 Sweden (28)
09 Switzerland (3)
10 USA (6)